亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

氟氯西林鈉

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫(kù)存 9999kg起訂1kg
型號(hào) 1847-24-1
過期 長(zhǎng)期有效
更新 2021-07-28 09:12
 

武漢遠(yuǎn)城嘉發(fā)膠原蛋白研究所

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2021-07-28
  • 陳經(jīng)理 (先生)   經(jīng)理
詳細(xì)說明
氟氯西林鈉 

產(chǎn)品名稱:氟氯西林鈉 

英文名稱:flucloxacillin sodium 

CAS 編號(hào):1847-24-1 

包裝規(guī)格:25kg紙板桶 

規(guī)格型號(hào):98%,醫(yī)藥級(jí) 




產(chǎn)品說明: 氟氯西林鈉 

藥物別名: 氟氯青霉素 

英文名稱: FlucloxacillinSodium 

說  明: 粉針劑:0.5g;膠囊劑:0.25g。 


氟氯西林鈉的功用作用: 用于產(chǎn)青霉素酶葡萄球菌所致的感染,如敗血癥、呼吸系統(tǒng)感染等。 


氟氯西林鈉的用法用量: 口服、肌內(nèi)注射:成人1.5g~3g/日,3~4次/日。 



氟氯西林鈉的注意事項(xiàng): 妊娠B類。過敏者禁用。宜空腹口服給藥,飯前1h為宜。 


關(guān)鍵詞:氟氯西林鈉的報(bào)價(jià),氟氯西林鈉的性狀,氟氯西林鈉的生產(chǎn)廠家,氟氯西林鈉
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
磷霉素 磷酸氯喹 磷酸泰樂菌素 硫氰酸鈉 氯菊酯 β-環(huán)狀糊精 β-紫羅蘭酮 阿苯達(dá)唑
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |